All Comments by Alexei Koudinov
- Toxicity of beta-amyloid vaccination in patients with Alzheimer's disease.
- Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
- Therapeutic vaccines: realities of today and hopes for the future.
- Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
- Immunization delays the onset of prion disease in mice.
- Potential neurotoxic inflammatory responses to Abeta vaccination in humans.
- Cholesterol and Alzheimer's disease.
- A novel mechanism for the regulation of amyloid precursor protein metabolism.
- Generation of amyloid beta peptide with pyroglutamate at position 3 in primary cortical neurons.
- The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset.
- Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease.
- Evolution of beta-amyloid induced neuropathology: magnetic resonance imaging and anatomical comparisons in the rodent hippocampus.
- Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain.
- beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
- Cholesterol metabolism in the brain.